These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 18423134

  • 1. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
    Yang QY, Sun XF, Huang HQ, Zhen ZJ, Xia Y, Cai QQ, Ling JY.
    Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
    [Abstract] [Full Text] [Related]

  • 2. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 3. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
    Calaminus G, Andreussi L, Garré ML, Kortmann RD, Schober R, Göbel U.
    Klin Padiatr; 1997 Dec; 209(4):222-7. PubMed ID: 9293454
    [Abstract] [Full Text] [Related]

  • 4. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004 Dec; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 5. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
    Khatua S, Dhall G, O'Neil S, Jubran R, Villablanca JG, Marachelian A, Nastia A, Lavey R, Olch AJ, Gonzalez I, Gilles F, Nelson M, Panigrahy A, McComb G, Krieger M, Fan J, Sposto R, Finlay JL.
    Pediatr Blood Cancer; 2010 Jul 15; 55(1):42-6. PubMed ID: 20222020
    [Abstract] [Full Text] [Related]

  • 6. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U, Bamberg M, Calaminus G, Gnekow AK, Herrmann HD, Lenard HG, Spaar HJ, Niethammer D, Kühl J, Harms D.
    Klin Padiatr; 1993 Jul 15; 205(4):217-24. PubMed ID: 7690863
    [Abstract] [Full Text] [Related]

  • 7. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M.
    Hinyokika Kiyo; 2007 Dec 15; 53(12):851-6. PubMed ID: 18203521
    [Abstract] [Full Text] [Related]

  • 8. Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol.
    Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL.
    J Clin Oncol; 2004 Mar 01; 22(5):846-53. PubMed ID: 14990640
    [Abstract] [Full Text] [Related]

  • 9. Primary chemotherapy for intracranial germ cell tumors: results of the third international CNS germ cell tumor study.
    da Silva NS, Cappellano AM, Diez B, Cavalheiro S, Gardner S, Wisoff J, Kellie S, Parker R, Garvin J, Finlay J.
    Pediatr Blood Cancer; 2010 Mar 01; 54(3):377-83. PubMed ID: 20063410
    [Abstract] [Full Text] [Related]

  • 10. Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.
    Hsu YJ, Pai L, Chen YC, Ho CL, Kao WY, Chao TY.
    Cancer; 2002 Aug 15; 95(4):766-74. PubMed ID: 12209720
    [Abstract] [Full Text] [Related]

  • 11. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ, Wong CK, Pozza LD, Waters KD, Lockwood L, Mauger DC, White L.
    Med Pediatr Oncol; 2002 Sep 15; 39(3):168-74. PubMed ID: 12210445
    [Abstract] [Full Text] [Related]

  • 12. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL, Fadel E, Ibrahim A, Bourhis JH, Droz JP.
    Bull Cancer; 1995 Sep 15; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [Abstract] [Full Text] [Related]

  • 13. [Germ-cell tumors of the central nervous system in childhood: retrospective study of 13 patients].
    Voirin J, Klein O, Chastagner P, Moret C, Vignaud JM, Auque J, Marchal JC.
    Neurochirurgie; 2008 Apr 15; 54(2):55-62. PubMed ID: 18355878
    [Abstract] [Full Text] [Related]

  • 14. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M, Miyake H, Hara I, Furukawa J, Takenaka A, Fujisawa M.
    Int J Urol; 2007 Apr 15; 14(4):336-8. PubMed ID: 17470166
    [Abstract] [Full Text] [Related]

  • 15. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 16. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H, Wolfe L, Kretschmar C.
    Pediatr Blood Cancer; 2009 Jul 15; 53(1):33-6. PubMed ID: 19326417
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, Rogers PC, Colombani P, Rescorla F, Billmire DF, Vinocur CD, Hawkins EP, Davis MM, Perlman EJ, London WB, Castleberry RP, Pediatric Oncology Group 9049, Children's Cancer Group 8882.
    J Clin Oncol; 2004 Jul 01; 22(13):2691-700. PubMed ID: 15226336
    [Abstract] [Full Text] [Related]

  • 18. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
    Kim JW, Kim WC, Cho JH, Kim DS, Shim KW, Lyu CJ, Won SC, Suh CO.
    Int J Radiat Oncol Biol Phys; 2012 Nov 01; 84(3):625-31. PubMed ID: 22420971
    [Abstract] [Full Text] [Related]

  • 19. Intensive cisplatin and cyclophosphamide-based chemotherapy without radiotherapy for intracranial germinomas: failure of a primary chemotherapy approach.
    Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL.
    Pediatr Blood Cancer; 2004 Aug 01; 43(2):126-33. PubMed ID: 15236278
    [Abstract] [Full Text] [Related]

  • 20. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S, Kramar A, Théodore C, Geoffrois L, Chevreau C, Biron P, Nguyen BB, Héron JF, Kerbrat P, Caty A, Delva R, Fargeot P, Fizazi K, Bouzy J, Droz JP, Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    J Clin Oncol; 2008 Jan 20; 26(3):421-7. PubMed ID: 18202419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.